Form 4 for EW Edwards Lifesciences
Accepted 2026-07-13 16:09:27 ET · period of report 2026-07-11 · accession 0001225208-26-006591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-13 16:09 | 2026-07-11 | EW | Bruls Annette | CVP, EMEACLA | F - Tax | $92.21 | -109 | 20.6K | -0.5% | -$10.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-11 | F | D | 109 | $92.21 | 20,628 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). |